Related Experiment Video
Updated: Feb 21, 2026

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
Manganese toxicity in critical care: Case report, literature review and recommendations for practice
Edward Walter1, Sinan Alsaffar1, Callum Livingstone2
1Department of Intensive Care, Royal Surrey County Hospital, Surrey, UK.
Abstract:
We present the case of a 62-year-old man on the intensive care unit with pancreatitis. Since early in his admission, and for the remainder of his prolonged stay in intensive care, he has received parenteral nutrition for intestinal failure. The whole blood manganese concentration was significantly increased after 2½ months of parenteral nutrition (PN). Three months into his stay, he developed a resting tremor and extra-pyramidal dyskinesia. In the absence of other neurological symptoms, and with no history of essential tremor, Parkinsonism or cerebral signs, hypermanganesaemia was presumed to be the cause. We review manganese metabolism and toxicity in patients who are fed with parenteral nutrition and review the current recommendations and guidelines.
Insights
A patient receiving parenteral nutrition developed manganese toxicity, leading to neurological symptoms like tremor and dyskinesia. This case highlights the importance of monitoring manganese levels in patients on long-term nutrition support.
Area of Science:
- Clinical Medicine
- Neuroscience
- Nutritional Science
Background:
- Parenteral nutrition (PN) is a life-sustaining treatment for intestinal failure.
- Manganese is an essential trace element, but excess can lead to toxicity.
- Long-term PN can alter trace element metabolism and increase toxicity risk.
Observation:
- A 62-year-old male patient in the ICU with pancreatitis received prolonged PN.
- Elevated whole blood manganese concentrations were observed after 2.5 months of PN.
- The patient subsequently developed resting tremor and extra-pyramidal dyskinesia.
Findings:
- Hypermanganesaemia was presumed to be the cause of the patient's neurological symptoms.
- The neurological presentation was distinct, with no other neurological deficits.
- This case underscores a potential link between PN and manganese neurotoxicity.
Implications:
- Routine monitoring of manganese levels in patients on long-term PN may be warranted.
- Further research into manganese metabolism and safe dosage in PN is needed.
- Clinical guidelines for trace element management in PN may require updates.
Related Concept Videos
Mitral Regurgitation IV: Nursing Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmaceutical Poisoning: Treatment Strategies
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Myocarditis IV: Nursing Management
Acute Kidney Injury VI: Nursing Management

